Eton Pharmaceuticals, Inc.
ETON · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $80.0M | $39.0M | +105% |
| Operating income | −$840K | −$2.60M | +67.7% |
| Net income | −$4.60M | −$3.82M | −20.4% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $57.9M | $22.5M | +157% |
| Operating income | $23.0M | −$1.40M | |
| Net income | $35.2M | −$1.90M |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Eton Pharmaceuticals's revenue in FY2025?
- $80.0M in FY2025 (Fiscal year ended Dec 31, 2025), +105% vs $39.0M a year earlier, per its 10-K filed Mar 2026.
- Was Eton Pharmaceuticals profitable in FY2025?
- No: net income was −$4.60M and operating income −$840K in FY2025.
- What was Eton Pharmaceuticals's revenue in Q3 2026?
- $57.9M (+157% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.